257 related articles for article (PubMed ID: 30332763)
1. Metabolomic Profiling of Portal Blood and Bile Reveals Metabolic Signatures of Primary Sclerosing Cholangitis.
Tietz-Bogert PS; Kim M; Cheung A; Tabibian JH; Heimbach JK; Rosen CB; Nandakumar M; Lazaridis KN; LaRusso NF; Sung J; O'Hara SP
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332763
[TBL] [Abstract][Full Text] [Related]
2. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.
Trottier J; Białek A; Caron P; Straka RJ; Heathcote J; Milkiewicz P; Barbier O
Dig Liver Dis; 2012 Apr; 44(4):303-10. PubMed ID: 22169272
[TBL] [Abstract][Full Text] [Related]
5. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.
Voigtländer T; Gupta SK; Thum S; Fendrich J; Manns MP; Lankisch TO; Thum T
PLoS One; 2015; 10(10):e0139305. PubMed ID: 26431155
[TBL] [Abstract][Full Text] [Related]
7. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
[TBL] [Abstract][Full Text] [Related]
8. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
[TBL] [Abstract][Full Text] [Related]
9. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
10. In vivo
Mohajeri S; Bezabeh T; Ijare OB; King SB; Thomas MA; Minuk G; Lipschitz J; Kirkpatrick I; Micflikier AB; Summers R; Smith ICP
NMR Biomed; 2019 May; 32(5):e4065. PubMed ID: 30735273
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta (TGF-beta) protein levels are not elevated in the blood or bile of patients with primary sclerosing cholangitis: a pilot study.
Watt JK; Hawkins K; Zhang M; Lipschitz J; Sandha G; Gong Y; Uhanova J; Minuk GY
Dig Dis Sci; 2004 Jan; 49(1):5-8. PubMed ID: 14992427
[TBL] [Abstract][Full Text] [Related]
12. Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.
Liu Q; Li B; Li Y; Wei Y; Huang B; Liang J; You Z; Li Y; Qian Q; Wang R; Zhang J; Chen R; Lyu Z; Chen Y; Shi M; Xiao X; Wang Q; Miao Q; Fang JY; Gershwin ME; Lian M; Ma X; Tang R
Gut; 2022 May; 71(5):899-909. PubMed ID: 34035120
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells.
von Seth E; Zimmer CL; Reuterwall-Hansson M; Barakat A; Arnelo U; Bergquist A; Ivarsson MA; Björkström NK
Eur J Immunol; 2018 Dec; 48(12):1997-2004. PubMed ID: 30252934
[TBL] [Abstract][Full Text] [Related]
14. Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis.
Braadland PR; Schneider KM; Bergquist A; Molinaro A; Lövgren-Sandblom A; Henricsson M; Karlsen TH; Vesterhus M; Trautwein C; Hov JR; Marschall HU
JHEP Rep; 2022 Nov; 4(11):100561. PubMed ID: 36176935
[TBL] [Abstract][Full Text] [Related]
15. S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
Reinhard L; Rupp C; Riedel HD; Ruppert T; Giese T; Flechtenmacher C; Weiss KH; Kloeters-Plachky P; Stremmel W; Schirmacher P; Sauer P; Gotthardt DN
PLoS One; 2012; 7(1):e29821. PubMed ID: 22253789
[TBL] [Abstract][Full Text] [Related]
16. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Guicciardi ME; Krishnan A; Bronk SF; Hirsova P; Griffith TS; Gores GJ
Cell Death Dis; 2017 Jan; 8(1):e2535. PubMed ID: 28055006
[TBL] [Abstract][Full Text] [Related]
17. Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
Voigtländer T; Wlecke J; Negm AA; Lenzen H; Manns MP; Lankisch TO
J Clin Gastroenterol; 2014; 48(10):866-9. PubMed ID: 24440929
[TBL] [Abstract][Full Text] [Related]
18. Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis.
Zweers SJ; Shiryaev A; Komuta M; Vesterhus M; Hov JR; Perugorria MJ; de Waart DR; Chang JC; Tol S; Te Velde AA; de Jonge WJ; Banales JM; Roskams T; Beuers U; Karlsen TH; Jansen PL; Schaap FG
Liver Int; 2016 Sep; 36(9):1370-7. PubMed ID: 26866350
[TBL] [Abstract][Full Text] [Related]
19. Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis.
Grant CW; Juran BD; Ali AH; Schlicht EM; Bianchi JK; Hu X; Liang Y; Jarrell Z; Liu KH; Go YM; Jones DP; Walker DI; Miller GW; Folseraas T; Karlsen TH; LaRusso NF; Gores GJ; Athreya AP; Lazaridis KN
Exposome; 2023; 3(1):osac011. PubMed ID: 36687160
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
